GNMSF - Genmab A/S (GMAB) CEO Jan van de Winkel on Q3 2020 Results - Earnings Call Transcript
Genmab A/S (GMAB) Q3 2020 Earnings Conference Call November 4, 2020 12:00 ET Company Participants Jan van de Winkel - President and Chief Executive Officer Anthony Pagano - Chief Financial Officer Judith Klimovsky - Chief Development Officer Anthony Mancini - Chief Operating Officer Conference Call Participants Wimal Kapadia - Bernstein Peter Verdult - Citi Kennen Mackay - RBC Capital Markets Trung Huynh - Credit Suisse Michael Schmidt - Guggenheim Sachin Jain - Bank of America Emily Field - Barclays David Ruch - SVB Greg Suvannavejh - Goldman Sachs Asthika Goonewardene - Truist Securities Peter Welford - Jefferies Presentation Jan van de Winkel So, hello and welcome to the general conference call to discuss the company’s financial results for the first 9 months of 2020. With me today to present these results is our CFO, Anthony Pagano. And for the Q&A, we will also welcome our Chief Development Officer, Judith Klimovsky;
For further details see:
Genmab A/S (GMAB) CEO Jan van de Winkel on Q3 2020 Results - Earnings Call Transcript